Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience
Aug 10, 04:30 PM
Share
Subscribe
In today's Pharmaceutical Executive Daily, Jazz Pharmaceuticals agrees to acquire Actio Biosciences, Novo Nordisk, Innate Pharma, and Innovent Biologics strike a trio of new partnerships, and a Veeva executive discusses how agentic AI is surfacing HCP insights that traditional field reporting has historically missed.